semaglutide causes gastroparesis GLP-1 Side Effects and Semaglutide: Why Smart Biomarker Monitoring Matters semaglutide causes gastroparesis 🚨 What

Together, these effects may contribute to modest reductions in body weight or body fat over time

Common gastrointestinal side effects reported with the 17.2 mg dose included nausea (35%), diarrhea (25%), constipation (24%), vomiting (24%), abdominal pain (14%), and dyspepsia (13%)

The tradeoff is regulatory: compounded products are not FDA-approved for safety and efficacy the way brand Zepbound is, so active provider supervision matters more, not less

"My hope is that they do their due diligence and have real monitoring of the patients taking the drugs," she said

Your providers documentation will need to reflect the clinical picture accurately

Compounded semaglutide and tirzepatide sit lower, often $200 to $350 a month, though availability shifted after the FDA shortage lists resolved